Jiangsu, China

Hongwei Liang

USPTO Granted Patents = 4 


Average Co-Inventor Count = 4.7

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018-2022

Loading Chart...
Loading Chart...
4 patents (USPTO):

Title: Innovations of Hongwei Liang in Gene Expression Suppression

Introduction

Hongwei Liang is a prominent inventor based in Jiangsu, China. He has made significant contributions to the field of biotechnology, particularly in the area of gene expression suppression. With a total of four patents to his name, Liang's work has the potential to impact cancer treatment and other medical applications.

Latest Patents

Liang's latest patents include innovative solutions for gene expression suppression. One of his notable inventions is an EGFR gene expression-suppressing siRNA, along with its precursor sequence and various applications. This invention provides a method to suppress EGFR gene expression, which is crucial in various cancer therapies. Another significant patent is the K-RAS gene expression-suppressing siRNA, which also includes its precursor sequences and applications. This siRNA effectively inhibits K-RAS gene expression, showing promising results in in vivo experiments for tumors that highly express K-RAS.

Career Highlights

Hongwei Liang is associated with Jiangsu Micromedmark Biotech Co., Ltd., where he continues to advance his research and development efforts. His work is characterized by a strong focus on practical applications of his inventions in the medical field.

Collaborations

Liang collaborates with talented individuals in his field, including Chenyu Zhang and Xi Chen. Their combined expertise enhances the innovative potential of their projects.

Conclusion

Hongwei Liang's contributions to gene expression suppression through his patents demonstrate his commitment to advancing biotechnology. His work holds promise for future medical applications, particularly in cancer treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…